• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

CEL-SCI Corp

AMEX:CVM

$0.43 -$0.01 (-2.15%)

REAL-TIME: Last trade at

CEL-SCI Corporation Releases Letter to Shareholders

CEL-SCI Corporation Releases Letter to Shareholders

CEL-SCI’s Chief Scientific Officer Presents at Cancer Symposium

Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System

CEL-SCI Corporation Reports Second Quarter 2012 Financial Results

Cel-Sci cuts losses

CEL-SCI Corporation Reports Second Quarter 2012 Financial Results

3 Rising Biotech Stocks To Keep A Close Eye On For Trading Profits

Cel-Sci Corp, Synergy Pharmaceuticals Stocks Rise: Investors Should Start Paying Attention

CEL-SCI Corporation, Tucows Among Stocks Gapping Up Monday

CEL-SCI Corporation, Tucows Among…

Get your bats out, Cel-Sci (AMEX:CVM) looks like a double form here (ASE,NAS:CVM,TEVA)

Cel-Sci Shares Still Undervalued: How Does This Make Sense?

Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm

Technical And Fundamental Breakout In Play For CEL-SCI Corporation

CEL-SCI and Human Genome Sciences Poised to Benefit From Favorable Legislation

Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug

CEL-SCI Corporation Pays off Convertible Debenture

CEL-SCI and Threshold Pharmaceuticals on the Upswing as FDA Optimism Grows

PennyStockCrew.com Volume Watch List: American Airlines (AMR), CEL-SCI Corporation (CVM), North Springs Resources (NSRS), Eastman Kodak (EK), Mustang Alliances (MSTG)

Cel-Sci looking for more sources of funding

CEL-SCI Corporation Reports First Quarter 2012 Financial Results

Cel-Sci looks for more funding

Corporate Profile's CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on CEL-SCI Corporation

Corporate Profile's CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on CEL-SCI Corporation

CEL-SCI volume suggests continued investor interest (ASE,NAS:CVM,TEVA)

2 Biotechs On Teva's Radar Screen

Cel-Sci volume surges after closing a $5.76M direct financing with institutional investor (ASE,NAS:CVM,TEVA)

Research Reports for Penny Stock Top Movers: Cemex, Janus Capital Group, Human Genome Sciences, CEL-SCI, Star Scientific and SLM

Cel-Sci raises more money

CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering

CEL-SCI to raise $5.76M in registered direct offering

CEL-SCI raises $5.76M in a registered direct offering

CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering

Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences

Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences

CEL-SCI says Multikine Phase III trial launched in dozens of hospitals

CEL-SCI Corporation Releases Letter to Shareholders

CEL-SCI Shares Continue To Rise On Heavy Buying

Healthcare Investment Conference Roudup

See More Articles...